FMP
RIGL icon

Financial Management Professionals’s Rigel Pharmaceuticals RIGL Stock Holding History

Financial Management Professionals’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-599
Closed -$25.7K – 1018
2025
Q4 		$25.7K Hold
599
– – ﹤0.01% 349
2025
Q3 		$17K Buy
+599
New +$17.9K ﹤0.01% 434

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Management Professionals's RIGL Position: Q1 2026 in Review

Financial Management Professionals sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 599 shares — an estimated $25.7K sold.

Financial Management Professionals first reported a position in RIGL in Q3 2025 and held it in 2 quarters. The position peaked at $25.7K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Financial Management Professionals reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Financial Management Professionals sold 599 Rigel Pharmaceuticals shares in Q1 2026, an estimated $25.7K.
  • Financial Management Professionals first reported a position in Rigel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Financial Management Professionals's Rigel Pharmaceuticals position peaked at $25.7K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Financial Management Professionals's 13F filing for Q1 2026, filed 15 Apr 2026.